7-2-Thiophen-2-yl-acetamide-3-{3-hydroxy-2-methyl-6-[3,5,12-trihydroxy-3-(2-hydroxy-acetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy]-tetrahydro-pyran-4-ylcarbamoyloxymethyl}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

ID: ALA283005

Chembl Id: CHEMBL283005

PubChem CID: 44278688

Max Phase: Preclinical

Molecular Formula: C42H41N3O17S2

Molecular Weight: 923.93

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3OC1CC(NC(=O)OCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cc4cccs4)[C@H]3SC2)C(O)C(C)O1

Standard InChI:  InChI=1S/C42H41N3O17S2/c1-16-33(49)21(43-41(57)60-14-17-15-64-39-31(38(54)45(39)32(17)40(55)56)44-25(48)9-18-5-4-8-63-18)10-26(61-16)62-23-12-42(58,24(47)13-46)11-20-28(23)37(53)30-29(35(20)51)34(50)19-6-3-7-22(59-2)27(19)36(30)52/h3-8,16,21,23,26,31,33,39,46,49,51,53,58H,9-15H2,1-2H3,(H,43,57)(H,44,48)(H,55,56)/t16?,21?,23-,26?,31+,33?,39+,42-/m0/s1

Standard InChI Key:  SCTKDLPCGYQKQB-VXPSJVQNSA-N

Associated Targets(Human)

H2981 cell line (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 923.93Molecular Weight (Monoisotopic): 923.1877AlogP: 0.81#Rotatable Bonds: 12
Polar Surface Area: 305.09Molecular Species: ACIDHBA: 18HBD: 8
#RO5 Violations: 3HBA (Lipinski): 20HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.36CX Basic pKa: CX LogP: 2.04CX LogD: -1.47
Aromatic Rings: 3Heavy Atoms: 64QED Weighted: 0.07Np Likeness Score: 0.78

References

1. Vrudhula VM, Svensson HP, Senter PD..  (1995)  Cephalosporin derivatives of doxorubicin as prodrugs for activation by monoclonal antibody-beta-lactamase conjugates.,  38  (8): [PMID:7731023] [10.1021/jm00008a016]

Source